Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hikma Pharmaceuticals Plc (HIK.LN)

Hikma Pharmaceuticals Plc (HIK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hikma Pharmaceuticals Plc 1 New Burlington Place London W1S 2HR GBR

https://www.hikma.com P: 207-399-2760

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

Key Statistics

Overview:

Market Capitalization, $K 3,394,858
Shares Outstanding, K 221,452
Annual Sales, $ 3,127 M
Annual Net Income, $ 359,000 K
% of Insider Shareholders 18.15%
% of Institutional Shareholders 63.62%

Growth:

1-Year Return -22.93%
3-Year Return -1.22%
5-Year Return -39.12%
5-Year Revenue Growth 7.22%
5-Year Earnings Growth -4.25%
5-Year Dividend Growth 12.79%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 1.67
EPS Growth vs. Prev Year 0.89%
Annual Dividend & Yield 0.80 (4.15%)
Annual Dividend & Yield (Fwd) 0.72 (4.15%)
Most Recent Dividend 0.360 on 08/14/25
Next Ex-Dividends Date 08/14/25
Dividend Payable Date 09/18/25
Dividend Payout Ratio 47.90%

HIK.LN Ratios

Ratio
Price/Earnings ttm 12.40
Price/Earnings forward 9.03
Return-on-Equity % 15.38%
Return-on-Assets % 7.13%
Profit Margin % 11.48%
Debt/Equity 0.28
Price/Sales 1.44
Price/Book 1.81
Book Value/Share 8.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar